Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes

Idiopathic multicentric Castleman disease (iMCD) is a rare hematologic disorder with an unknown etiology. Clinical presentation is heterogeneous, ranging from mild constitutional symptoms with lymphadenopathy to life-threatening multiorgan dysfunction. International, consensus treatment guidelines d...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierson, Sheila K., Lim, Megan S., Srkalovic, Gordan, Brandstadter, Joshua D., Sarmiento Bustamante, Mateo, Shyamsundar, Saishravan, Mango, Natalie, Lavery, Criswell, Austin, Bridget, Alapat, Daisy, Lechowicz, Mary Jo, Bagg, Adam, Li, Hongzhe, Casper, Corey, van Rhee, Frits, Fajgenbaum, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637880/
https://www.ncbi.nlm.nih.gov/pubmed/37656441
http://dx.doi.org/10.1182/bloodadvances.2023010745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637880/
https://www.ncbi.nlm.nih.gov/pubmed/37656441
http://dx.doi.org/10.1182/bloodadvances.2023010745

Ejemplares similares